Wells Fargo & Company Clearside Biomedical, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 50 shares of CLSD stock, worth $72. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 558 91.04%

Holding current value

$72

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.08 - $1.58 $548 - $802	-508 Reduced 91.04%	50 $0
Q1 2024 May 10, 2024	BUY	$1.2 - $2.02 $111 - $187	93 Added 20.0%	558 $0
Q4 2023 Feb 09, 2024	BUY	$0.68 - $1.18 $16 - $28	24 Added 5.44%	465 $0
Q3 2023 Nov 13, 2023	BUY	$0.82 - $1.27 $10 - $16	13 Added 3.04%	441 $0
Q2 2023 Aug 15, 2023	BUY	$0.97 - $1.48 $23 - $35	24 Added 5.94%	428 $0
Q1 2023 May 12, 2023	BUY	$0.93 - $1.66 $5 - $9	6 Added 1.51%	404 $0
Q4 2022 Feb 13, 2023	BUY	$1.0 - $1.5 $9 - $13	9 Added 2.31%	398 $0
Q3 2022 Nov 14, 2022	BUY	$1.08 - $1.83 $1 - $1	1 Added 0.26%	389 $0
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.49 $439 - $841	338 Added 676.0%	388 $0
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $1 - $2	-1 Reduced 1.96%	50 $0
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $829 - $1,744	-305 Reduced 85.67%	51 $0
Q3 2021 Nov 15, 2021	SELL	$4.83 - $7.2 $77 - $115	-16 Reduced 4.3%	356 $2,000
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $176 - $408	76 Added 25.68%	372 $2,000
Q1 2021 May 13, 2021	BUY	$2.24 - $4.25 $49 - $93	22 Added 8.03%	296 $1,000
Q4 2020 Feb 09, 2021	SELL	$1.32 - $2.74 $55,773 - $115,773	-42,253 Reduced 99.36%	274 $1,000
Q3 2020 Nov 05, 2020	SELL	$1.45 - $2.0 $4,028 - $5,556	-2,778 Reduced 6.13%	42,527 $66,000
Q2 2020 Aug 13, 2020	BUY	$1.55 - $2.41 $69,818 - $108,556	45,044 Added 17258.24%	45,305 $85,000
Q1 2020 May 14, 2020	BUY	$1.32 - $3.77 $344 - $983	261 New	261 $0

Others Institutions Holding CLSD

# of Institutions

Shares Held

13.4M

Call Options Held

17.6K

Put Options Held

100

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $87.3M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Clearside Biomedical, Inc. Transaction History